Product Code: RP-ID-10151871 |
Published Date: 21 Oct 2022 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151871
Market Overview:
Global Protein Expression Industry Market Research 2022-2030
Shorter expression time and structural modification are some of the main characteristics of protein expression, and these characteristics have led to an increasing demand for proteins. Cell-free protein expression uses cell lysates to produce the required recombinant protein.
The main advantage of this technology is that it avoids workflow barriers that keep cells in culture or cell viable. The cell lysate is produced by. Degradation and use of cellular components of eukaryotic or bacterial cells.
Currently, there are several types based on E. E. coli, rabbit reticulocytes, wheat germ, human cell lines and insect cells. Compared with protein expression based on living cells, the in vitro protein expression system has significant advantages, including shorter process duration, protein isotope labeling, incorporation of unnatural amino acids, optimization of protein complexes, unnatural incorporation of amino acids, and natural And profitability.
In addition, these technologies also allow the production of proteins that are toxic to host cells in recombinant technology. Therefore, considering the importance of protein expression, the research market is expected to grow during the forecast period.
Report scope:
Protein expression refers to the way in which proteins are modified, synthesized and regulated in organisms. The term protein research applies to both the research object and the laboratory techniques required to make proteins. According to the function of the host cell, it needs to regulate and synthesize protein.
Main market trends:
During the forecast period, cell-free expression will grow at a constant rate. Cell-free protein expression has been widely accepted in the market, and this expression is done without the use of living cells. Compared with other protein expression technologies, this technology has many advantages and is widely used due to its advantages. Due to the advantages of cell-free protein technology, such as increased speed, ability to express toxic proteins, and ease of selective labeling of amino acid types, they are making this cell expression market grow. They include high-throughput screening of truncated proteins, the production of proteins that are toxic to the expression host in vivo, the expression of proteins with amino acids, and the incorporation of post-translational modifications. The latest trend in the field of cell-free expression research is protein nanocrystallography. This technique can form and characterize stable protein crystallites with up to atomic resolution. This unique technology may promote the growth of the cell-free expression market, which is expected to promote the development of the protein expression market.
The United States has the largest market share and is expected to do so during the forecast period:
The US protein expression market is currently the most progressive and profitable in the world, and it holds the largest share of the global protein expression market. protein. The US protein expression market is driven by factors such as investment in research activities, increased use of protein technology, and the rapid development of the pharmaceutical industry in the region. Other factors driving the development of the US protein expression market include several companies in the region itself. The increase in research intensity of the US pharmaceutical industry has increased market growth opportunities. In the United States, opportunities in the field of proteomics have further boosted the market. However, strict FDA regulatory policies are hindering the growth of the protein expression market.
Competitive landscape:
The protein expression market is moderately competitive, mainly dominated by multinational companies. Local companies have also developed good business in many countries such as India and China. With the increase in R&D activities in the pharmaceutical industry, new companies are entering the research market, and it is believed that they will occupy a considerable share in the near future.
Major Players
Agilent Technologies
Bio-Rad Laboratories, Inc.
Merck KGaA
Qiagen
Thermo Fisher Scientific Inc.
Related Reports
Proof of Quality & Reliability
